IHS Chemical Week

Regions :: China

Merck KGaA to invest €80 million to build pharmaceutical facility in China

11:38 AM MST | November 15, 2013 | Deepti Ramesh

Merck KGaA (Darmstadt, Germany) says its biopharmaceutical division Merck Serono (Darmstadt), will invest €80 million ($107 million) to build a new pharmaceutical manufacturing facility in the Nantong Economical Technological Development Area, in the Greater Shanghai region. The facility will focus on the bulk production and packaging of Glucophage, Concor, and Euthyrox, Merck’s brands for the treatment of diabetes, cardiovascular diseases, and thyroid disorders, respectively. Construction on the facility is scheduled to start in 2014 and will be...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa